Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220161 · ClinicalTrials.gov registry record · NA
Trigeminal Nerve Stimulation of the Treatment of Epilepsy
A NA study of Epilepsy (Treatment Refractory), sponsored by Baylor College of Medicine.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07220161 is a NA study of Epilepsy (Treatment Refractory) that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07220161, a NA study of Epilepsy (Treatment Refractory), is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Epilepsy is a common neurological disorder among veterans. Medications do not control seizures in 1/3rd of patients, who often require neurostimulation. However, current neurostimulation devices are invasive. Objective: The investigators propose a novel clinical trial to repurpose the FDA-approved Cefaly device, designed for migraine relief, to treat epilepsy. The Cefaly device works by non-invasive Trigeminal neurostimulation (TNS). TNS has previously shown promising preliminary results in seizure improvement. Design: The investigators will engage 24 veterans with drug-resistant epilepsy, half of whom will receive standard care, while the other half will receive standard care plus Cefaly. This will be followed by a crossover of the treatment/control groups. The primary objective is to evaluate seizure frequency improvement over 12 months.
Conditions Studied
Interventions
- DEVICE Trigeminal nerve stimulation
Study Locations (1)
Texas
- Debakey VA Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07220161
The ClinicalTrials.gov registry entry for NCT07220161 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy (Treatment Refractory) appearing as the primary indexed condition, and to 1 intervention - of which Trigeminal nerve stimulation is the first listed.
NCT07220161 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07220161 about?
NCT07220161 is a clinical study titled "Trigeminal Nerve Stimulation of the Treatment of Epilepsy". Background: Epilepsy is a common neurological disorder among veterans. Medications do not control seizures in 1/3rd of patients, who often require neurostimulation. However, current neurostimulation devices are invasive. Objective: The investigators propose a novel clinical trial to repurpose the FD...
What is the current status of trial NCT07220161?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-05-08. Estimated completion is 2026-06-30.
What conditions does trial NCT07220161 study?
This clinical trial studies the following conditions: Epilepsy (Treatment Refractory).
What interventions are being tested in trial NCT07220161?
The interventions under investigation include: Trigeminal nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT07220161?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220161 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy (Treatment Refractory)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.